Liu et al. demonstrated that ligand-mediated EPHA2 activation enhanced glioblastoma proliferation and tumor growth via a mitogen-activated protein kinase (MAPK) dependent pathway [74]. This evidence concerns the gene EPHA2 and neoplasm.